BerGenBio ASA logo

BerGenBio ASA

OSE:BGBIO.OL

Overview | Financials
Company Name BerGenBio ASA
Symbol BGBIO.OL
Currency NOK
Price 0.152
Market Cap 398,320,548
Dividend Yield 0%
52-week-range 0.075 - 9.8
Industry Biotechnology
Sector Healthcare
CEO Mr. Martin Olin
Website https://www.bergenbio.com

An error occurred while fetching data.

About BerGenBio ASA

BerGenBio ASA, a clinical-stage biopharmaceutical company, engages in development of drugs to treat immune evasive, drug resistant, and metastatic cancers; and respiratory diseases. Its lead candidate is Bemcentinib, a bio-available small molecule AXL inhibitor, which is in Phase II clinical development in major cancer indications and COVID-19. Its Phase II

Related Stocks

Hofseth BioCare ASA logo

Hofseth BioCare ASA

HBC.OL

2.7 NOK

Nordhealth AS logo

Nordhealth AS

NORDH.OL

23.4 NOK

Carasent ASA logo

Carasent ASA

CARA.OL

11.5 NOK

Navamedic ASA logo

Navamedic ASA

NAVA.OL

36.8 NOK

Ultimovacs ASA logo

Ultimovacs ASA

ULTI.OL

107.4 NOK

Photocure ASA logo

Photocure ASA

PHO.OL

54 NOK

Financials

Numbers are in millions USD

Numbers are in millions USD